Sagent Pharmaceuticals explores sale, say sources: Reuters

Sagent Pharmaceuticals Inc, a U.S. generic life sciences company focusing on injectable drugs, is considering a sale of the company as part of an exploration of strategic alternatives, according to people familiar with the matter.

13 January 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles